Skip to main content

Table 2 Baseline characteristics of the Study Population

From: Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging

 

CA

Patients

N = 10

Healthy

Controls

N = 10

p-value

Age [years]

60 ± 11

62 ± 11

0.79

Male (%)

7 (70)

6 (60)

0.73

BSA [m2]

1.80 ± 0.13

1.85 ± 0.18

0.50

AL-Amyloidosis

8 (80)

  

ATTR-Amyloidosis

2 (20)

  

IVS [mm]

14.4 ± 2.6

8.0 ± 1.3

< 0.001

LVEDV [ml]

134 ± 25

133 ± 20

0.97

LVMi [g/m2]

79 ± 19

44 ± 7

<  0.001

LVEF [%]

64.0 ± 6.3

60.7 ± 3.9

0.20

GLS [%]

−16.6 ± 3.3

−22.4 ± 1.9

< 0.001

GCS [%]

−26.9 ± 5.5

−29.1 ± 3.1

0.30

  1. Data are mean ± SD or number of patients (%)
  2. AL amyloid light chain, ATTR transthyretin-associated amyloidosis, BSA body surface area, CA cardiac amyloidosis, GCS global circumferential strain, GLS global longitudinal strain, IVS interventricular septum thickness in diastole, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVMi left ventricular mass indexed to body surface area
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us